Liminatus Pharma Inc. (LIMN)

Last Closing Price: 1.19 (2025-10-21)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Liminatus Pharma Inc. (LIMN) had Net Income of $0.11M for the most recently reported fiscal quarter, ending 2025-06-30.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
--
Net Income
$0.11M
--
--
$1.12M
$-1.12M
$1.23M
$0.11M
$0.11M
$0.11M
$0.11M
$0.11M
$0.11M
$-1.12M
$-1.12M
23.30M
23.30M
$0.00
$0.00
Balance Sheet Financials
$1.78M
$0.00M
$0.13M
$1.91M
$10.52M
--
$0.20M
$10.72M
$-8.81M
$-8.81M
$-8.81M
26.02M
Cash Flow Statement Financials
$-8.98M
$-0.78M
$11.03M
$0.06M
$1.34M
$1.28M
--
--
--
Fundamental Metrics & Ratios
0.17
--
--
--
-0.16
--
--
--
--
--
--
$-8.98M
--
--
--
--
--
--
--
-1.29%
-1.29%
5.93%
-1.29%
$-0.34
$-0.39
$-0.39